ZEKE CAPITAL ADVISORS, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2022$4,557,410
+0.6%
50,236
-15.7%
0.30%
-9.7%
Q3 2022$4,531,000
-10.1%
59,610
-0.0%
0.33%
-1.5%
Q2 2022$5,041,000
+6.8%
59,638
+10.9%
0.34%
+40.8%
Q1 2022$4,718,000
+12.1%
53,770
+11.7%
0.24%
-3.3%
Q4 2021$4,210,000
+18.7%
48,129
+11.0%
0.25%
+20.0%
Q3 2021$3,547,000
-11.7%
43,377
-1.5%
0.20%
-19.0%
Q2 2021$4,018,000
+7.9%
44,035
+1.1%
0.25%
-2.3%
Q1 2021$3,724,000
-9.5%
43,5630.0%0.26%
-23.4%
Q4 2020$4,114,000
+219.2%
43,563
+193.8%
0.34%
+126.8%
Q3 2020$1,289,000
-1.5%
14,828
-1.0%
0.15%
-40.9%
Q2 2020$1,309,000
-2.9%
14,983
-8.4%
0.25%
-33.9%
Q1 2020$1,348,000
-71.2%
16,352
-66.9%
0.38%
-2.1%
Q4 2019$4,683,000
+10.0%
49,461
+1.0%
0.39%
+3.2%
Q3 2019$4,257,000
-4.1%
48,988
+0.8%
0.38%
-9.8%
Q2 2019$4,437,000
-3.9%
48,597
+1.2%
0.42%
-2.8%
Q1 2019$4,619,000
+14.2%
48,043
+1.9%
0.43%
+11.1%
Q4 2018$4,044,000
-6.7%
47,125
-6.3%
0.39%
+9.0%
Q3 2018$4,333,000
+17.4%
50,286
+2.9%
0.36%
+3.2%
Q2 2018$3,692,000
+925.6%
48,877
+998.9%
0.34%
+942.4%
Q1 2018$360,000
-7.0%
4,448
-3.6%
0.03%
-19.5%
Q4 2017$387,000
+69.0%
4,615
+72.7%
0.04%
+32.3%
Q3 2017$229,000
+2.7%
2,6730.0%0.03%
-27.9%
Q2 2017$223,000
-8.2%
2,673
-18.3%
0.04%
-14.0%
Q1 2017$243,0003,2730.05%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders